CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
189 hedge funds and large institutions have $1.61B invested in Cymabay Therapeutics in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+38
Holders Change %
+25.17%
% of All Funds
3.01%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.19%
New
63
Increased
57
Reduced
52
Closed
24
Calls
$35M
Puts
$32.9M
Net Calls
+$2.15M
Net Calls Change
-$1.47M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$103M |
| 2 |
Holocene Advisors
New York
|
$46.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$36.2M |
| 4 |
FAM
Fred Alger Management
New York
|
$32.4M |
| 5 |
Jennison Associates
New York
|
$53M |
